Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety

被引：4
|
作者：
Suissa, Samy [1 ,2 ,3 ]
机构：
[1] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Med, Montreal, PQ, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 03期
关键词：
D O I：
10.1183/13993003.00883-2023
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?
    Rothnie, Kieran
    Czira, Alexandrosz
    Compton, Chris
    Banks, Vicky
    Wood, Robert
    Tritton, Theo
    Thomas, Joseph
    Massey, Olivia
    Blackburn, Stuart
    Wild, Rosie
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [22] Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review
    Miranda, Juan Antonio Riesco
    Rubiob, Myriam Calle
    Perez, David Diaz
    Lopez-Campos, Jose Luis
    Carreroe, Juan Antonio Trigueros
    Cellif, Bartoloma
    ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (01): : 55 - 58
  • [23] REAL-WORLD ADHERENCE TO SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL VERSUS MULTIPLE-INHALER TRIPLE THERAPY AMONG ASTHMA PATIENTS IN THE US
    Averell, C.
    Germain, G.
    Laliberte, F.
    MacKnight, S.
    Jung, Y.
    Duh, M. S.
    Abbott, C.
    VALUE IN HEALTH, 2021, 24 : S13 - S13
  • [24] Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in England
    Noorduyn, Stephen G.
    Wood, Robert P.
    Rothnie, Kieran J.
    Rai, Kiran K.
    Seif, Monica
    Massey, Lucy
    Compton, Chris
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [25] Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review
    Rana, Rezwanul Hasan
    Alam, Khorshed
    Keramat, Syed Afroz
    Gow, Jeff
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (10) : 1067 - 1084
  • [26] COST-EFFECTIVENESS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS TIOTROPIUM MONOTHERAPY IN PATIENTS WITH COPD IN THE UK
    Martin, A.
    Shah, D.
    Shukla, S.
    Kendall, R.
    Risebrough, N. A.
    Compton, C.
    Ismaila, A.
    VALUE IN HEALTH, 2022, 25 (01) : S40 - S40
  • [27] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [28] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Vallejo-Aparicio, L. A.
    Paly, V. F.
    Schroeder, M.
    Martin, A.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S878 - S878
  • [29] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36
  • [30] Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan
    Oga, Toru
    Mita, Chifuku
    Ito, Risako
    Requena, Gema
    Rothnie, Kieran J.
    Noorduyn, Stephen G.
    Yuanita, Liza
    Yarita, Masao
    RESPIRATORY INVESTIGATION, 2024, 62 (04) : 685 - 694
12345